|
|

|
 |
|
|
|
| |
- Efficacy and Safety of Tri-Luma in the Treatment of Patients with Cutaneous Melanosis of the Face (Melasma). Hill Dermaceuticals, Inc.
- Placebo controlled Phase-IV Study to Evaluate the Benefit of Tazarotene 0.1% Gel in the Treatment of Active Pseudofolliculitis Barbae (PFB) in Patients with Skin of Color. Allergan
- Placebo Controlled Phase-IV Study of Efficacy of Tazarotene Cream 0.1% in the Treatment of Acne Keloidalis Nuchae. Allergan
- Development and Validation of the Hyperpigmentation Scale. Galderma
- Placebo Controlled Phase-IV Study of Efficacy and Tolerability of Benzaclin Gel in the Treatment of Pseudofolliculitis Barbae. Dermik.
- Evaluation of the Hair Care and Grooming Practices of African American Women with Alopecia.
- Safety and Efficacy of Dapsone in the Treatment of Facial Acne. Atrix
- Safety and Efficacy of Metrolotion in the Treatment of Seborrheic Dermatitis. Galderma
- Safety and Efficacy of Loprox Shampoo for Seborrheic Dermatitis. Medicis.
- Safety and Efficacy of Tri-Luna for the Treatment of Pseudofolliculitis Barbae.
Galderma.
- Safety and Efficacy of Etanercept in the Treatment of Subjects with Psoriasis. Amgen.
|
|
|
| © 2006 Society Hill Dermatology |
|